Abstract
Hepatic micrometastases of the parenchyma adjacent to a macroscopic lesion were detected in 17 of 31 resected liver metastases. Fifty-nine micrometastatic lesions were detected in total; 26 lesions were situated in the portal vein (PV), 22 in the central vein (CV), 5 in the bile duct (BD), and 6 in the sinusoid (SS). A histological study confirmed the direct invasion of the macrometastatic cancer cells into the adjacent PV, CV, BD, and SS. According to the tumor doubling time, the mean diameter of the macrometastases in 19 remnant livers was calculated to have been 0.57±0.87 cm at the time of the primary resection. The calculated diameter of 3 of these 19 macrometastases was found to be less than 0.01 cm, the minimum implantable size, indicating that the cancer recurrence in these specimens may have developed from macroscopic metastatic lesions as a satellite, and not from the primary tumor. In 13 patients who received doses of 5250 mg or more of 5 fluorouracil (FU) via the hepatic artery, the cumulative disease-free rate 2 years postoperatively was 100%; this value was 47.6% in 11 patients who received less than 5250 mg of 5 FU via the hepatic artery, and 0% in 39 patients who received no chemotherapy (P<0.005). These results suggest that anatomical hepatic resection for satellite lesions, combined with prophylactic hepatic arterial chemotherapy for micrometastases, decreases the recurrence rate of hepatic metastases in the remnant liver.
Similar content being viewed by others
References
Hughes KS (1986) Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 100:278–284
Scheele J, Stangle R, Hofmann A, Gall FP (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13–29
Nordlinger B, Parc R, Delva E, Quilichini M-A, Hannoun L, Huguet C (1987) Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrence in 80 patients. Ann Surg 205:250–263
Ekberg H, Trauberg K-G, Anderson R, Lundstedt C, Hagerstrand I, Ranstam J (1987) Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 11:541–547
Que FG, Nagorney DM (1994) Resection of recurrent colorectal metastases to the liver. Br J Surg 81:255–258
Griffith KD, Sugarbaker PH, Chang AE (1990) Repeat hepatic resection for colorectal metastases. Surgery 81:101–104
Foster JH, Lundi J (1981) Liver metastases. Curr Probl Surg 18:157–202
Cady B, McDermott WV (1985) Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 201:204–209
Fortner JG, Silva JS, Golbey RB (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer: Treatment by hepatic resection. Ann Surg 198:306–316
Halm A, Broadley E, Aldrete JS (1989) Hepatic resection of metastases from colorectal carcinoma. Morbidity, mortality and pattern of recurrence. Ann Surg 209:428–434
Stehlin JS, De Ipolyi PD, Greeff PJ (1988) Treatment of cancer of the liver. Ann Surg 208:23–35
Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F (1991) One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 78:797–801
Bozzetti F, Bignami P, Morabito A (1987) Patterns of failure following surgical resection of colorectal cancer liver metastases. Ann Surg 205:246–270
Stone MD, Cady B, Jenkins RL (1990) Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg 125:718–721
Isono T, Miyazaki M, Udagawa I (1992) Clinicopathological study of micrometastasis in hepatic metastases (in Japanese). Nihon Gan Chiryo Gakkaishi (J Jpn Soc Cancer Ther) 27:893–899
Nanko M (1994) Micrometastasis in the liver with macrometastasis of colorectal cancer (in Japanese). Yokohama Igaku (Yokohama Med J) 45:229–235
Collins VP, Loeffler RK, Tivey H (1956) Observation on growth rates of human tumors. Am J Roentgenol 76:988–1000
Collins VP (1962) Time of occurrence of pulmonary metastases from carcinoma of colon and rectum. Cancer 15:387–395
Sugarbaker PH, Kemeny N (1989) Management of the metastatic cancer to the liver. Adv Surg 2:1–56
Morrow CE, Grage TB, Sutherland DER, Najarian JS (1982) Hepatic resection for secondary neoplasms. Surgery 92:610–613
O'Connel M, Adson M, Schutt A, Rubin J, Moertel C, Ilstrup D (1985) Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastasis to the liver. Mayo Clin Proc 60:517–520
Breedis C, Young C (1954) The blood supply of neoplasms in the liver. Am J Pathol 30:969–986
Patt YZ, McBride CM, Ames FC, Claghorn LJ, Cleary KR, Boddie AW (1987) Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 59:867–873
Kemeny N, Goldbey D, Beatty JO, Blayney D, Browning S, Doroshou J (1986) Result of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57:492–496
Author information
Authors and Affiliations
About this article
Cite this article
Shimada, H., Nanko, M., Fujii, S. et al. Treatment strategies for hepatic metastasis from colorectal cancer. J Hep Bil Pancr Surg 2, 116–121 (1995). https://doi.org/10.1007/BF02348735
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02348735